Abingdon Health (ABDX) Competitors

In the previous week, Yourgene Health had 1 more articles in the media than Abingdon Health. MarketBeat recorded 1 mentions for Yourgene Health and 0 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.72 beat Yourgene Health's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the news media.

Abingdon Health has lower revenue, but higher earnings than Yourgene Health. Abingdon Health is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 3.7% of Abingdon Health shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 8.0% of Abingdon Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Yourgene Health has a net margin of -27.55% compared to Abingdon Health's net margin of -33.88%. Yourgene Health's return on equity of -27.06% beat Abingdon Health's return on equity.

Yourgene Health has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.117, suggesting that its stock price is 88% less volatile than the broader market.

In the previous week, Abingdon Health's average media sentiment score of 0.72 beat GENinCode's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the media.

Abingdon Health has higher revenue and earnings than GENinCode. Abingdon Health is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Abingdon Health has a beta of 0.117, suggesting that its stock price is 88% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.608, suggesting that its stock price is 39% less volatile than the broader market.

3.7% of Abingdon Health shares are owned by institutional investors. Comparatively, 4.8% of GENinCode shares are owned by institutional investors. 8.0% of Abingdon Health shares are owned by company insiders. Comparatively, 8.6% of GENinCode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Abingdon Health has a net margin of -33.88% compared to GENinCode's net margin of -170.49%. Abingdon Health's return on equity of -55.91% beat GENinCode's return on equity.

Abingdon Health has a beta of 0.117, meaning that its share price is 88% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

3.7% of Abingdon Health shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 8.0% of Abingdon Health shares are owned by insiders. Comparatively, 2.7% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, ANGLE had 1 more articles in the media than Abingdon Health. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.72 beat ANGLE's score of -0.15 indicating that Abingdon Health is being referred to more favorably in the media.

Abingdon Health has a net margin of -33.88% compared to ANGLE's net margin of -732.40%. Abingdon Health's return on equity of -55.91% beat ANGLE's return on equity.

14.4% of Verici Dx shares are held by institutional investors. Comparatively, 3.7% of Abingdon Health shares are held by institutional investors. 1.2% of Verici Dx shares are held by company insiders. Comparatively, 8.0% of Abingdon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Abingdon Health has a net margin of -33.88% compared to Verici Dx's net margin of -468.31%. Abingdon Health's return on equity of -55.91% beat Verici Dx's return on equity.

Verici Dx has a beta of 1.401, meaning that its share price is 40% more volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.117, meaning that its share price is 88% less volatile than the broader market.

Abingdon Health has higher revenue and earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

In the previous week, Verici Dx had 1 more articles in the media than Abingdon Health. MarketBeat recorded 1 mentions for Verici Dx and 0 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.72 beat Verici Dx's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the news media.